{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T18:45:46Z","timestamp":1784832346966,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Changhai hospital \u201c1255\u201d fund","award":["CH125540800"],"award-info":[{"award-number":["CH125540800"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2829-5","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T14:14:14Z","timestamp":1476800054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration"],"prefix":"10.1186","volume":"16","author":[{"given":"Yue","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng-Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Mei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,18]]},"reference":[{"issue":"6","key":"2829_CR1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jso.21128","volume":"98","author":"MZ Papa","year":"2008","unstructured":"Papa MZ, Zippel D, Kaufman B, Shimon-Paluch S, Yosepovich A, Oberman B, et al. Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer. J Surg Oncol. 2008;98(6):403\u20136.","journal-title":"J Surg Oncol"},{"key":"2829_CR2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14:609\u201318.","journal-title":"Lancet Oncol"},{"issue":"9","key":"2829_CR3","volume":"9","author":"JF Fu","year":"2014","unstructured":"Fu JF, Chen HL, Yang J, Yi CH, Zheng S. Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis. PLoS One. 2014;9(9), e105316.","journal-title":"PLoS One"},{"key":"2829_CR4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ciresp.2014.01.004","volume":"93","author":"A Pinero-Madrona","year":"2015","unstructured":"Pinero-Madrona A, Escudero-Barea MJ, Fernandez-Robayna F, Alberro-Ad\u00fariz JA, Garc\u00eda-Fern\u00e1ndez A, Vicente-Garc\u00eda F, et al. Selective sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer: results of the GEICAM 2005\u201307 study[J]. Cir Esp. 2015;93:23\u20139.","journal-title":"Cir Esp"},{"key":"2829_CR5","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310:1455\u201361.","journal-title":"JAMA"},{"key":"2829_CR6","doi-asserted-by":"crossref","first-page":"9304","DOI":"10.1200\/JCO.2005.02.5023","volume":"23","author":"BT Hennessy","year":"2005","unstructured":"Hennessy BT, Hortobagyi GN, Rouzier R, Kuerer H, Sneige N, Buzdar AU, et al. Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol. 2005;23:9304\u201311.","journal-title":"J Clin Oncol"},{"key":"2829_CR7","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cncr.25152","volume":"116","author":"LS Dominici","year":"2010","unstructured":"Dominici LS, Negron Gonzalez VM, Buzdar AU, Lucci A, Mittendorf EA, Le-Petross HT, et al. Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer. Cancer. 2010;116:2884\u20139.","journal-title":"Cancer"},{"key":"2829_CR8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347.","journal-title":"Eur J Cancer"},{"key":"2829_CR9","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","volume":"23","author":"GH Lyman","year":"2005","unstructured":"Lyman GH, Giuliano AE, Somerfield MR, Benson 3rd AB, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703\u201320.","journal-title":"J Clin Oncol"},{"key":"2829_CR10","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/cncr.22540","volume":"109","author":"J Shen","year":"2007","unstructured":"Shen J, Gilcrease MZ, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, et al. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer. 2007;109:1255\u201363.","journal-title":"Cancer"},{"key":"2829_CR11","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1245\/s10434-007-9403-y","volume":"14","author":"EA Newman","year":"2007","unstructured":"Newman EA, Sabel MS, Nees AV, Schott A, Diehl KM, Cimmino VM, et al. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol. 2007;14:2946\u201352.","journal-title":"Ann Surg Oncol"},{"key":"2829_CR12","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.clbc.2013.08.014","volume":"13","author":"H Yagata","year":"2013","unstructured":"Yagata H, Yamauchi H, Tsugawa K, Hayashi N, Yoshida A, Kajiura Y, et al. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer. Clin Breast Cancer. 2013;13:471\u20137.","journal-title":"Clin Breast Cancer"},{"key":"2829_CR13","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1245\/s10434-013-2992-8","volume":"20","author":"S Park","year":"2013","unstructured":"Park S, Park JM, Cho JH, Park HS, Kim SI, Park BW, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis. Ann Surg Oncol. 2013;20:2858\u201365.","journal-title":"Ann Surg Oncol"},{"key":"2829_CR14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33:258\u201364.","journal-title":"J Clin Oncol"},{"key":"2829_CR15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4048\/jbc.2015.18.1.22","volume":"18","author":"JY Kim","year":"2015","unstructured":"Kim JY, Kim MK, Lee JE, Jung Y, Bae SY, Lee SK, et al. Sentinel lymph node biopsy alone after neoadjuvant chemotherapy in patients with initial cytology-proven axillary node metastasis. J Breast Cancer. 2015;18:22\u20138.","journal-title":"J Breast Cancer"},{"key":"2829_CR16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.amjsurg.2005.06.004","volume":"190","author":"JL Jones","year":"2005","unstructured":"Jones JL, Zabicki K, Christian RL, et al. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. Am J Surg. 2005;190:517\u201320.","journal-title":"Am J Surg"},{"key":"2829_CR17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10147-012-0418-4","volume":"18","author":"H Takei","year":"2013","unstructured":"Takei H, Yoshida T, Kurosumi M, Gadd MA, Hughes KS, Lesnikoski BA, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation. Int J Clin Oncol. 2013;18:547\u201353.","journal-title":"Int J Clin Oncol"},{"key":"2829_CR18","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1002\/cncr.25066","volume":"116","author":"AS Brown","year":"2010","unstructured":"Brown AS, Hunt KK, Shen J, Babiera GV, Ross MI, Meric-Bernstam F, et al. Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment. Cancer. 2010;116:2878\u201383.","journal-title":"Cancer"},{"key":"2829_CR19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/bjs.4840","volume":"92","author":"H Charfare","year":"2005","unstructured":"Charfare H, Limongelli S, Purushotham AD. Neoadjuvant chemotherapy in breast cancer. Br J Surg. 2005;92:14\u201323.","journal-title":"Br J Surg"},{"key":"2829_CR20","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","volume":"23","author":"EP Mamounas","year":"2005","unstructured":"Mamounas EP, Brown A, Anderson S, Julian T, Miller B, Bear HD, et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol. 2005;23:2694\u2013702.","journal-title":"J Clin Oncol"},{"key":"2829_CR21","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","volume":"8","author":"DN Krag","year":"2007","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8:881\u20138.","journal-title":"Lancet Oncol"},{"key":"2829_CR22","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/SLA.0b013e3181b8fd5e","volume":"250","author":"KK Hunt","year":"2009","unstructured":"Hunt KK, Yi M, Mittendorf EA, Guerrero C, Babiera GV, Bedrosian I, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg. 2009;250:558\u201366.","journal-title":"Ann Surg"},{"key":"2829_CR23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/01.sla.0000165200.32722.02","volume":"241","author":"RC Martin 2nd","year":"2005","unstructured":"Martin 2nd RC, Chagpar A, Scoggins CR, Edwards MJ, Hagendoorn L, Stromberg AJ, et al. Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg. 2005;241:1005\u201312. discussion 12\u20135.","journal-title":"Ann Surg"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2829-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T16:32:52Z","timestamp":1657470772000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2829-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,18]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2829"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2829-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,18]]},"article-number":"808"}}